argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
738.26
-14.06 (-1.87%)
Sep 17, 2025, 2:56 PM EDT - Market open
argenx SE Market Cap
argenx SE has a market cap or net worth of $45.48 billion as of September 17, 2025. Its market cap has increased by 46.94% in one year.
Market Cap
45.48B
Enterprise Value
41.56B
1-Year Change
46.94%
Ranking
Category
Stock Price
$738.26
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $45.48B, an increase of 7,259.99%. That is a compound annual growth rate of 67.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 45.92B | 24.86% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |